Trial NCT04244552

View at ClinicalTrials.gov 
Org. Study IDs: ATRC-101-A01

Last trial update was posted on 2023-12-29

MeSH Interventions

Doxorubicin Liposomal doxorubicin Pembrolizumab

MeSH Conditions

Breast Neoplasms Carcinoma Carcinoma, Ovarian Epithelial Carcinoma, Squamous Cell Colorectal Neoplasms Esophageal Squamous Cell Carcinoma Melanoma Ovarian Neoplasms Squamous Cell Carcinoma of Head and Neck Triple Negative Breast Neoplasms

Other Conditions

Acral Lentiginous Melanoma Breast Cancer Colorectal Cancer DMMR Colorectal Cancer Head and Neck Squamous Cell Carcinoma Hepatocellular Carcinoma MSI-H Colorectal Cancer Non-Small Cell Lung Cancer Ovarian Cancer Platinum-Resistant Epithelial Ovarian Cancer Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma Triple Negative Breast Cancer Urothelial Carcinoma

Stopping Reasons

Sponsor Decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID